For Media: UK Press Releases
This page contains resources intended for journalists only. For media enquiries about our press releases please contact ukmediaenquiries@bayer.com
Bayer receives positive CHMP opinion for acoramidis for treatment of adults with transthyretin amyloid cardiomyopathy with UK MHRA submission underway
Bayer starts Phase I study with SOS1 inhibitor in patients with advanced KRAS-mutated tumours
BlueRock Therapeutics’ investigational cell therapy bemdaneprocel for Parkinson’s disease shows positive data at 24-months
Bayer submits application to MHRA for elinzanetant to treat moderate to severe vasomotor systems associated with menopause in women
Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer